Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  soy isoflavones
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-19 of 19 for your search:
Start Over
Phase III Placebo-Controlled Study of Soy Phytoestrogens in the Management of Hot Flashes in Women with a History of Breast Cancer (Summary Last Modified 08/98)
Phase: Phase III
Type: Supportive care
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCCTG-969258, NCI-P97-0126
Phase III Randomized Study of Isoflavones in Reducing Risk Factors in Patients With Stage I or II Prostate Cancer
Phase: Phase III
Type: Prevention
Status: Completed
Age: 50 to 80
Sponsor: NCI
Protocol IDs: MCC-0002, NCI-4031, NCI-P01-0195, NCT00027950
Role of Soy Supplementation in Prostate Cancer Development
Phase: Phase III
Type: Biomarker/Laboratory analysis, Natural history/Epidemiology, Tissue collection/Repository
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: CLIN-006-05S, NCT00255125
Phase III Randomized Study of Soy Protein/Isoflavones and Venlafaxine on Vasomotor Symptoms in Patients With Prostate Cancer Undergoing Hormonal Manipulation
Phase: Phase III
Type: Supportive care
Status: Closed
Age: 21 and over
Sponsor: NCI
Protocol IDs: CCCWFU-97405, CCCWFU 97405, WFU-97405, CCCWFU-BG05-529, NCT00354432
Soy Isoflavones in Treating Patients Who Are Undergoing Radical Prostatectomy for Stage I or Stage II Adenocarcinoma of the Prostate
Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000353197, P30CA022453, WSU-C-2418, NCT00078923
Soy Isoflavones and Breast Cancer Risk Reduction
Phase: Phase II
Type: Prevention
Status: Closed
Age: 30 to 42
Sponsor: NCI
Protocol IDs: 03-260, UTMB GCRC #635, R01CA095545, M01RR000073, 1UL1RR029876-01, NCT00204490
Soy Supplements in Treating Patients Undergoing Surgery for Localized Prostate Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: Over 18
Sponsor: NCI, Other
Protocol IDs: CDR0000466317, CCCWFU-98203, CCCWFU-BG03-332, NCT00345813
Vitamin D and Soy Supplements in Treating Patients With Recurrent Prostate Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: Over 18
Sponsor: NCI, Other
Protocol IDs: CDR0000554969, P30CA012197, CCCWFU-85106, CCCWFU-IRB00000371, NCT00499408
Soy Derivatives for Control of Hot Flashes in Men on Androgen Deprivation Therapy
Phase: Phase II
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: 9639, NCT00594620
The Specific Role of Isoflavones in Reducing Prostate Cancer Risk
Phase: Phase II
Type: Treatment
Status: Completed
Age: 50 to 80
Sponsor: Other
Protocol IDs: MCC-12835, NCI #4031, CA 81920, NCT00617617
Phase II Clinical Trial of Purified Isoflavones in Prostate Cancer: Comparing Safety, Effectiveness
Phase: Phase II
Type: Treatment
Status: Closed
Age: 30 to 80
Sponsor: Other
Protocol IDs: MCC-15835, IRB 107980, 1P20MD003375-01, NCT01036321
Isoflavones & Lycopene in Localized Prostate Ca:Prior to Radical Prostatectomy
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 45 to 80
Sponsor: NCI, Other
Protocol IDs: MCC-13004, NCI-3811, NCI-P02-0216, 0105, MCC-0105, HLMCC 0105, NCT00042731
Calcitriol or Placebo in Men for Prostate Cancer Active Surveillance
Phase: No phase specified
Type: Treatment
Status: Closed
Age: 45 and over
Sponsor: Other
Protocol IDs: PROS0022, 97408, NCT00482157
Soy, Selenium and Breast Cancer Risk
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Prevention
Status: Completed
Age: 35 to 50
Sponsor: Other
Protocol IDs: R14697, 07/Q0101/10, NCT00555386
High Risk Prostate Cancer Prevention Study
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Prevention, Tissue collection/Repository
Status: Completed
Age: 55 to 95
Sponsor: Other
Protocol IDs: 12052, NCT01174953
Soy Isoflavones Supplementation in Treating Women at High Risk For or With Breast Cancer
Phase: No phase specified
Type: Diagnostic, Prevention, Treatment
Status: Closed
Age: 30 to 75
Sponsor: NCI, Other
Protocol IDs: 1B-10-6, NCI-2010-01847, NCT01219075
Start Over